炎症因子在脓毒症中的应用进展

ISSN:2705-098X(P)

EISSN:2705-0505(O)

语言:中文

作者
陈嘉琦,甘桂芬
文章摘要
脓毒症是感染诱发的全身炎症反应综合征(SIRS),其核心病理机制为炎症因子网络失衡引发的“免疫紊乱-组织损伤-多器官功能障碍”级联反应,是全球重症医学领域病死率最高的疾病之一。本文系统梳理炎症因子在脓毒症中的作用机制、动态演变规律,重点阐述其作为生物标志物的诊断、病情评估及预后预测价值,深入分析靶向炎症因子的治疗策略的研究进展与临床转化现状,并针对当前存在的异质性、治疗窗口精准性等问题,提出多组学整合、个体化诊疗等未来发展方向。研究表明,动态监测炎症因子谱可显著提升脓毒症诊疗效率,而新型靶向疗法为改善患者预后提供了新路径,未来需进一步推动基础研究与临床实践的深度融合,构建脓毒症精准诊疗体系。
文章关键词
脓毒症;炎症因子;生物标志物;靶向治疗;免疫调节;多器官功能障碍综合征
参考文献
[1] 王林川,汤雪梅,向春林,等.星状神经节阻滞治疗脓毒症相关器官功能障碍的作用机制及临床应用研究进展[J/OL].华西医学, 1-7[2025-08-26]. [2] 叶蕊,汪驰,丁霏,等.脓毒症诊疗:病原体与宿主免疫状态检测新进展[J/OL].华西医学,1-6[2025-08-26]. [3] 荣吉林太,张瑞芬,苏和,等.基于TLR-4/NF-κB信号通路探讨中医药治疗脓毒症的机制研究[J/OL].重庆医科大学学报,1-10[2025-08-26]. [4] Wong L H,Lie Y H H,Wong F T,et al.A rare case of spontaneous kidney rupture from xanthogranulomatous pyelonephritis presenting with neurological symptoms and septic peritonitis.[J].Urology case reports,2025,62 103155. [5] Tuinte M A R,Smolenaers J P L,Knoop T B,et al.Development and validation of an interpretable machine learning model for retrospective identification of suspected infection for sepsis surveillance:a multicentre cohort study.[J].EClinicalMedicine,2025,87 103401. [6] Liu Y,Zheng C,Liu X,et al.Early prediction of sepsis-induced cardiorenal syndrome:superiority of myoglobin over troponin I.[J].Renal failure,2025,47(1):2542523. [7] Weijden D V M B,Janssen M C W S,Weide D V C M,et al.Safety and effectiveness of the early-onset sepsis calculator to reduce antibiotic exposure in at-risk newborns:a cluster-randomised controlled trial.[J].EClinicalMedicine,2025,87 103419. [8] Akiboye D,Leung Y,Taheem M,et al.Investigating raised white cells,sepsis and antibiotic administration in obstructive urolithiasis:A retrospective cohort analysis[J].Journal of Clinical Urology,2025,18(5):399-408. [9] 吴欣欣,宋海涛,董春丽,等.SOFA评分、SI、ACCI联合对脓毒症患者28天死亡率的预测价值[J].中国实验诊断学,2025,29(08):942-947. [10] 张艳梅,朱丽超,李晓晓,等.老年重症肺炎伴脓毒症患者发生凝血功能紊乱的影响因素及风险预测模型构建[J].中国疗养医学, 2025,34(09):95-99. [11] 王卓琦,谭晶,费露颍,等.脓毒症心肌功能障碍的研究现状和中西医疗法[J/OL].中西医结合心脑血管病杂志,2025, (16):2481-2485[2025-08-26]. [12] 余绍坤,王荣辉,徐保转,等.中药单体治疗脓毒症急性肾损伤的研究进展[J/OL].实用中医内科杂志,1-6[2025-08-26]. [13] 王成连,谢树花,刘尧萍,等.硬膜外镇痛对脓毒症胃肠道屏障功能的影响[J].黑龙江医药,2025,38(04):792-795. [14] Jia A,Wang Y,Zhou R,et al.USP48 promotes NLRP3-dependent pyroptosis of alveolar macrophages to exacerbate sepsis-induced acute lung injury[J].International Immunopharmacology,2025,162 115140-115140. [15] Kiya T G,Mekonnen Z,Asefa T E,et al.Bacterial isolates and antibiotic resistance in critically ill sepsis patients at a tertiary hospital in Ethiopia[J].BMC Infectious Diseases,2025,25(1):1046-1046. [16] Corrigendum to"Cognitive Health and Quality of Life After Surviving Sepsis:A Narrative Review".[J].Journal of intensive care medicine,2025,8850666251370162. [17] Zhang J,Xia J,Niu Z,et al.Association of stress hyperglycemia ratio with mortality in sepsis-associated acute kidney injury:a retrospective analysis of the MIMIC-IV database[J].Scientific Reports,2025,15(1):30667-30667. [18] 黄静,王铭铭,刘敬轩,等.绿原酸调节Nrf2/GPX4信号通路干预脓毒症致急性肝损伤大鼠铁死亡的机制探究[J].中国兽医杂志,2025,61(08):37-45. [19] 熊晓灿,余平.基于JAK2-STAT3通路探究巴马汀抗脓毒症炎性反应机制[J].贵州医科大学学报,2025,50(08):1196-1206. [20] 吕媛媛,赵春霞,何莎莎.参附黄方通过抑制GSDMD介导的细胞焦亡减轻脓毒症诱导的小鼠肠损伤[J].中草药,2025, 56(16):5856-5868. [21] 王璐璐,黄成,孙明月,等.早期血清降钙素原、血钠及脑利钠肽水平对脓毒症和脓毒症休克患者预后判断的价值[J].西部医学, 2025,37(08):1216-1219+1226. [22] Tan W,Duan R,Zeng C,et al.Association Between Malnutrition and Sepsis-Associated Delirium:A Retrospective Analysis of the MIMIC-IV Database.[J].Nursing in critical care,2025,30(5):e70130. [23] Li Z,Wang H,Zhou Q,et al.Melatonin Inhibits CD4+T Cell Apoptosis via the Bcl-2/BAX Pathway and Improves Survival Rates in Mice With Sepsis.[J].Journal of pineal research,2025,77(5):e70071. [24] Zhao Y,Qu Y,Huang C,et al.Neutrophils loaded NAD+impede TLR4/NF-κB/NLRP3 pathway for sepsis treatment.[J].Materials today.Bio,2025,34 102168. [25] Li B,Li J,Zhu Z,et al.FGF15/FGFR4 signaling suppresses M1 macrophage polarization and multi-organ inflammation in septic mice by inhibiting H3K18 lactylation-driven Irf7 expression through NF2-Hippo activation[J].Cell Death&Disease,2025,16(1):628-628. [26] Peksöz R,Ağırman E,TavacıT,et al.Protective effects of avasopasem manganese(GC4419)against sepsis-induced acute lung injury:A comprehensive experimental study.[J].European journal of clinical investigation,2025,e70111. [27] Correction to:CircEXOC5 Aggravates Sepsis-Induced Acute Lung Injury by Promoting Ferroptosis Through the IGF2BP2/ATF3 Axis. [J].The Journal of infectious diseases,2025. [28] Watanabe M,Ikeda M,Abe K,et al.Excessive HIF-1αdriven by phospholipid metabolism causes septic cardiomyopathy through cytopathic hypoxia[J].Nature Cardiovascular Research,2025,(prepublish):1-17. [29] Ceccato A,Scheer S C,Ferrer R,et al.Regional sepsis care in Catalonia:comparative insights from a secondary analysis of the European Sepsis Care Survey[J].Critical Care,2025,29(1):367-367. [30] Papareddy P,Lobo J T,Holub M,et al.Transforming sepsis management:AI-driven innovations in early detection and tailored therapies[J].Critical Care,2025,29(1):366-366.
Full Text:
DOI